{
    "clinical_study": {
        "@rank": "87297", 
        "arm_group": [
            {
                "arm_group_label": "Migraine group", 
                "description": "Patients diagnosed with migraine"
            }, 
            {
                "arm_group_label": "Healthy group", 
                "description": "Healthy subjects with no migraine as control"
            }
        ], 
        "brief_summary": {
            "textblock": "The researchers investigated the relationship between migraine and allergy. For this\n      purpose, the researchers designed a controlled study to evaluate nasal symptoms and signs;\n      and to perform Specific Immunoglobulin E  (IgE) measurements in migraine patients and\n      healthy subjects. According to these results the prevalence of allergic rhinitis in migraine\n      group was planned to be compared to that of the healthy controls, statistically."
        }, 
        "brief_title": "Is There a Comorbidity Between Migraine and Allergic Rhinitis?", 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Migraine", 
            "Allergic Rhinitis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Rhinitis", 
                "Migraine Disorders"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients with migraine\n\n        Exclusion Criteria:\n\n          -  other neurologic disorders that may contribute to headaches, such as stroke, cerebral\n             palsy, trigeminal neuralgia, and seizure disorder\n\n          -  also acute and chronic sinusitis."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Migraine patients attending neurology clinic and healthy subjects"
            }
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01845051", 
            "org_study_id": "CC-01"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Migraine", 
            "allergic rhinitis", 
            "Specific Immunoglobulin E (IgE)", 
            "nasal symptoms", 
            "signs of allergy."
        ], 
        "lastchanged_date": "May 1, 2013", 
        "number_of_groups": "2", 
        "other_outcome": {
            "description": "inferior concha colour (0=natural, 1=pale, 2=bluish and 3=severely pale or bluish) and turbinate edema were assessed during ENT examination on 0-3 scale (0 = no, 1 = mild, 2 = moderate, 3 = severe).", 
            "measure": "\u0130nferior turbinate color and edema", 
            "safety_issue": "No", 
            "time_frame": "1 day"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Turkey: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Blood samples were taken from study and control group for the determination of Specific IgE panel against six different allergens: (1) fungi, (2) grass pollens, (3) tree pollens, (4) wild herbs, (5) mite 1, (6) mite 2. For all of specific IgE panels, <0,7 RU/ml was negative; and >0,7 RU/ml was Positive.", 
                "measure": "Specific Immunoglobulin E (IgE)", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }, 
            {
                "description": "Symptoms were assessed with a questionnaire for the presence and severity of allergic rhinitis (AR) symptoms on a scale of 0-3 (0 = none, 1 = mild, 2 = moderate, 3 = severe). Symptoms of AR (Nasal discharge, nasal congestion, itching and sneezing) were graded between 0-3.", 
                "measure": "Nasal Symptom Scores", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01845051"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Baskent University", 
            "investigator_full_name": "I\u015f\u0131l Adadan G\u00fcven\u00e7", 
            "investigator_title": "MD, ENT Specialist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Baskent University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Baskent University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2013"
    }
}